Beryl Drugs Balance Sheet Annual

BSE: - | NSE: - | ISIN: - | Sector: -

22.20 -0.01 (-0.05%)Updated : 20 Jul 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	14.96	15.96	17.49	17.51
Cash Equivalents	0.27	0.81	0.12	0.28
Other Liabilities Total	0.51	0.42	0.40	0.40
Long Term Debt	0.00	1.74	2.40	2.72
Common Stock Total	5.09	5.09	5.09	5.09
Other Current Assets Total	1.14	0.74	0.72	0.79
Total Assets	14.96	15.96	17.49	17.51
Current Portof LT Debt/ Capital Leases	2.39	0.32	0.31	0.23
Total Equity	9.89	9.50	8.92	8.07
Long Term Investments	0.41	0.43	0.43	0.50
Retained Earnings( Accumulated Deficit)	4.79	4.41	3.83	2.97
Total Common Shares Outstanding	0.51	0.51	0.51	0.51
Tangible Book Valueper Share Common Eq	19.49	18.74	17.59	15.90
Total Liabilities	5.08	6.46	8.56	9.45
Total Debt	2.44	4.07	5.09	4.54
Short Term Investments	0.20	0.13	0.54	1.28
Cashand Short Term Investments	0.47	0.94	0.66	1.56
Total Receivables Net	2.09	5.46	7.58	6.92
Deferred Income Tax	0.04	-	-	-
Accounts Receivable- Trade Net	2.09	5.46	7.58	6.90
Property/ Plant/ Equipment Total- Net	6.82	6.00	5.96	5.81
Total Current Liabilities	4.48	4.30	5.76	6.33
Total Inventory	3.13	1.90	1.26	1.05
Accounts Payable	1.43	1.12	2.02	3.25
Other Currentliabilities Total	0.66	0.85	1.05	1.26
Total Long Term Debt	0.05	1.74	2.40	2.72
Intangibles Net	0.00	0.00	0.00	0.00
Other Long Term Assets Total	0.90	0.48	0.88	0.89
period Length	0.00	0.00	0.00	0.00
Total Current Assets	6.83	9.04	10.22	10.32
Capital Lease Obligations	0.05	-	-	-
Notes Payable/ Short Term Debt	-	2.02	2.38	1.59
Other Equity Total	-	-	-	0.00